135 related articles for article (PubMed ID: 34918592)
1. Novel and efficient method for loading aptamer-conjugated liposomes with arsenic trioxide for targeting cancer cells.
Mirveis Z; Kouchak M; Mahdavinia M; Rahbar N
J Liposome Res; 2022 Sep; 32(3):276-283. PubMed ID: 34918592
[TBL] [Abstract][Full Text] [Related]
2. AS1411aptamer conjugated liposomes for targeted delivery of arsenic trioxide in mouse xenograft model of melanoma cancer.
Shariat Razavi F; Kouchak M; Sistani Karampour N; Mahdavinia M; Nazari Khorasgani Z; Rezaie A; Rahbar N
J Liposome Res; 2024 Jun; 34(2):288-302. PubMed ID: 37843918
[TBL] [Abstract][Full Text] [Related]
3. RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells.
Khosravani F; Amiri F; Mahmoudi R; Morshedi D; Kobarfard F; Alipour M; Hosseini E; Bardania H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2347-2357. PubMed ID: 37831114
[TBL] [Abstract][Full Text] [Related]
4. Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study.
Akhtar A; Wang SX; Ghali L; Bell C; Wen X
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617346
[TBL] [Abstract][Full Text] [Related]
5. Liposome-Coated Arsenic-Manganese Complex for Magnetic Resonance Imaging-Guided Synergistic Therapy Against Carcinoma.
Jin Z; Yi X; Yang J; Zhou M; Wu P; Yan G
Int J Nanomedicine; 2021; 16():3775-3788. PubMed ID: 34113100
[TBL] [Abstract][Full Text] [Related]
6. Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release.
Chen H; MacDonald RC; Li S; Krett NL; Rosen ST; O'Halloran TV
J Am Chem Soc; 2006 Oct; 128(41):13348-9. PubMed ID: 17031934
[TBL] [Abstract][Full Text] [Related]
7. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
8. Optimisation of Folate-Mediated Liposomal Encapsulated Arsenic Trioxide for Treating HPV-Positive Cervical Cancer Cells In Vitro.
Akhtar A; Ghali L; Wang SX; Bell C; Li D; Wen X
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052347
[TBL] [Abstract][Full Text] [Related]
9. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
10. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
[TBL] [Abstract][Full Text] [Related]
11. pH-Responsive and liver-targeting drug delivery system for combination delivery of artesunate with arsenic trioxide prodrug against hepatocellular carcinoma.
Pan X; Huang J; Liu S; Shao Y; Xi J; He R; Shi T; Zhuang R; Yu W
Drug Dev Ind Pharm; 2023 Aug; 49(8):485-496. PubMed ID: 37470495
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide liposomes: encapsulation efficiency and in vitro stability.
Kallinteri P; Fatouros D; Klepetsanis P; Antimisiaris SG
J Liposome Res; 2004; 14(1-2):27-38. PubMed ID: 15461930
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide encapsulated liposomes prepared via copper acetate gradient loading method and its antitumor efficiency.
Wang S; Liu C; Wang C; Ma J; Xu H; Guo J; Deng Y
Asian J Pharm Sci; 2020 May; 15(3):365-373. PubMed ID: 32636954
[TBL] [Abstract][Full Text] [Related]
14. Polymeric micelles for GSH-triggered delivery of arsenic species to cancer cells.
Zhang Q; Vakili MR; Li XF; Lavasanifar A; Le XC
Biomaterials; 2014 Aug; 35(25):7088-100. PubMed ID: 24840615
[TBL] [Abstract][Full Text] [Related]
15. Angiopep-2-modified calcium arsenite-loaded liposomes for targeted and pH-responsive delivery for anti-glioma therapy.
Xu H; Li C; Wei Y; Zheng H; Zheng H; Wang B; Piao JG; Li F
Biochem Biophys Res Commun; 2021 Apr; 551():14-20. PubMed ID: 33714754
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide liposome gels for the treatment of psoriasis in mice.
Liu L; Ji F; Zhao Y; Hai X
J Liposome Res; 2024 Jun; 34(2):264-273. PubMed ID: 37621197
[TBL] [Abstract][Full Text] [Related]
17. Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide.
Chen H; Ahn R; Van den Bossche J; Thompson DH; O'Halloran TV
Mol Cancer Ther; 2009 Jul; 8(7):1955-63. PubMed ID: 19567824
[TBL] [Abstract][Full Text] [Related]
18. A study on the preparation and characterization of plasmid DNA and drug-containing magnetic nanoliposomes for the treatment of tumors.
Wang ZY; Wang L; Zhang J; Li YT; Zhang DS
Int J Nanomedicine; 2011; 6():871-5. PubMed ID: 21720500
[TBL] [Abstract][Full Text] [Related]
19. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-based liposomes improve specific drug loading and release.
Plourde K; Derbali RM; Desrosiers A; Dubath C; Vallée-Bélisle A; Leblond J
J Control Release; 2017 Apr; 251():82-91. PubMed ID: 28238787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
